Friends star Matthew Perry’s death has shed light on the use of ketamine infusion therapy for treating depression. The actor had been undergoing this treatment, which involves the use of ketamine to alleviate symptoms of depression, anxiety, and pain.
However, the coroner’s report revealed that Perry’s death was not directly caused by the ketamine infusion therapy. Instead, prosecutors allege that he was supplied with the drug illicitly by five individuals, including two doctors, his assistant, and an alleged drug dealer.
Ketamine is known for its dissociative effects, which can distort perceptions and produce calming and relaxing sensations. It is also used illicitly and can have negative side effects such as increased heart rate, confusion, and bladder problems.
Ketamine infusion therapy is a treatment option for individuals with treatment-resistant depression. It involves administering ketamine intravenously in smaller doses than those used for anaesthesia. The treatment acts faster than traditional antidepressants but its effects wear off quickly, requiring close monitoring of patients for relapse.
While ketamine has shown positive results for some patients, it is not without risks. Experts caution that individuals may still experience negative side effects, even under medical supervision. It is important to carefully consider the potential benefits and risks of ketamine therapy before undergoing treatment.
In Perry’s case, the high concentration of ketamine in his blood at the time of his death and the timing of his last infusion session ruled out ketamine infusion therapy as the cause of his death. Prosecutors allege that his assistant administered a high dosage of ketamine in the days leading up to his passing.
The tragic death of Matthew Perry serves as a reminder of the complexities and risks associated with mental health treatments, and the importance of proper oversight and regulation in the administration of such therapies.
